Pre-Tax Income: Company's earnings or loss before taxes on income have been accounted for.
Gossamer Bio, Inc. (GOSS) had Pre-Tax Income of $-46.66M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
$16.95M |
|
$-46.66M |
|
-- |
|
$16.95M |
|
$61.82M |
|
$-44.87M |
|
$-1.80M |
|
|
Pre-Tax Income |
$-46.66M |
$-46.66M |
|
$-46.66M |
|
$-46.66M |
|
$-46.66M |
|
$-46.66M |
|
$-44.87M |
|
$-45.04M |
|
234.14M |
|
234.14M |
|
$-0.20 |
|
$-0.20 |
|
| Balance Sheet Financials | |
$124.54M |
|
$0.06M |
|
$4.36M |
|
$128.90M |
|
$56.51M |
|
$198.76M |
|
$233.88M |
|
$290.38M |
|
$-161.48M |
|
$-161.48M |
|
$-161.48M |
|
234.70M |
|
| Cash Flow Statement Financials | |
$-38.72M |
|
$41.61M |
|
$0.51M |
|
$37.73M |
|
$41.03M |
|
$3.30M |
|
$6.30M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.20 |
|
-- |
|
-- |
|
5.33 |
|
-1.23 |
|
100.00% |
|
-264.62% |
|
-264.62% |
|
-- |
|
-275.22% |
|
-275.22% |
|
$-38.72M |
|
-- |
|
-- |
|
-- |
|
0.13 |
|
-- |
|
1.83 |
|
49.11 |
|
28.90% |
|
28.90% |
|
-36.20% |
|
-125.17% |
|
$-0.69 |
|
$-0.17 |
|
$-0.17 |
|